Ever wonder why the rate of Ebola infection increased a staggering 1000% in a matter of weeks?
Or why mega-banks bought hundreds of thousands of shares in a little-known pharmaceutical company—Tekmira—developing an Ebola vaccine—all on the same day, June 30, 2014?